908 Devices (MASS) Short term Debt (2020 - 2026)

908 Devices (MASS) posted quarterly Short term Debt of $22.4 million for Q1 2026, up 39.82% quarter-over-quarter from $16.0 million in Q4 2025.

908 Devices (MASS) Short term Debt (2020 - 2026) Analysis & Trends

908 Devices (MASS) has reported Short term Debt for 5 consecutive years, with $22.4 million the latest figure, recorded in Q1 2026.

In Q1 2026, Short term Debt changed N/A year-over-year to $22.4 million; the TTM figure through Mar 2026 stood at $22.4 million (changed N/A YoY), while the FY2025 annual figure was $16.0 million, changed N/A from the prior year.
Short term Debt grew to $22.4 million in Q1 2026 per MASS's latest filing, from $16.0 million in the prior quarter.
Across five years, Short term Debt topped out at $23.0 million in Q3 2025 and bottomed at $500000.0 in Q4 2023.
Historically, Short term Debt has averaged $8.6 million across 4 years, with a median of $1.2 million in 2022.
On a YoY basis, Short term Debt climbed as much as 59.77% in 2023 and fell as far as 59.77% in 2023.
908 Devices' Short term Debt stood at $1.2 million in 2022, then slumped by 59.77% to $500000.0 in 2023, then surged by 3105.0% to $16.0 million in 2025, then soared by 39.82% to $22.4 million in 2026.
Business Quant data shows MASS's Short term Debt at $22.4 million in Q1 2026, $16.0 million in Q4 2025, and $23.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.22 Bn	196.62 Bn	7.27 Bn
2	Stryker	126.75 Bn	123.28 Bn	4.50 Bn
3	Medtronic	119.49 Bn	110.27 Bn	6.41 Bn
4	Boston Scientific	74.69 Bn	74.15 Bn	3.85 Bn
5	Edwards Lifesciences	51.85 Bn	47.59 Bn	1.35 Bn
6	Dexcom	34.83 Bn	32.88 Bn	830.00 Mn
7	GE HealthCare Technologies	33.81 Bn	31.70 Bn	2.18 Bn
8	Koninklijke Philips	26.31 Bn	22.99 Bn	4.55 Bn
9	Steris	23.22 Bn	22.74 Bn	684.20 Mn
10	908 Devices	387.46 Mn	285.93 Mn	8.34 Mn

Download Data